Sugao H, Yamazaki S, Shiozawa H, Yano K
Novel Pharma Laboratories Institute for Drug Development Research, Shizuoka, Japan.
J Pharm Sci. 1998 Jan;87(1):96-100. doi: 10.1021/js970104g.
Indeloxazine hydrochloride (IDX), a cerebral activator, has a bitter astringent taste. To prepare powders of IDX without this bitter taste, microparticles (median diameter, 130 microns) of IDX were coated with a mixture comprising hydrogenated oil and surfactants in a fluidized bed using the side-spray method. Drug release from the resulting coated particles was significantly delayed. Dissolution rate was remarkably enhanced, however, by heat-treating the coated particles at a temperature above the melting point of the surfactant in the coated layer. The results of differential scanning calorimetry measurements show that part of the surfactant in the coated layer exists separately. Further, surface changes in the coated layer before and after heat treatment showed that this enhancement of dissolution rate was due to rediffusion of the surfactant in the coated layer followed by melting of the surfactant. This effect allows the design of powders of IDX which release the drug quickly and with bioequivalence to the commercial IDX 20 mg tablets while sufficiently suppressing the bitter taste.
盐酸茚洛秦(IDX)是一种脑激活剂,有苦涩味。为制备无此苦味的IDX粉末,采用侧喷法在流化床中用包含氢化油和表面活性剂的混合物对IDX微粒(中位直径130微米)进行包衣。所得包衣颗粒的药物释放显著延迟。然而,通过在高于包衣层中表面活性剂熔点的温度下对包衣颗粒进行热处理,溶出速率显著提高。差示扫描量热法测量结果表明,包衣层中的部分表面活性剂是单独存在的。此外,热处理前后包衣层的表面变化表明,这种溶出速率的提高是由于表面活性剂在包衣层中再扩散,随后表面活性剂熔化。这种效应使得能够设计出IDX粉末,其能快速释放药物,且与市售IDX 20 mg片剂具有生物等效性,同时充分抑制苦味。